Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listVLX1570

VLX1570

  • CAS NO.:1431280-51-1
  • Empirical Formula: C23H17F2N3O6
  • Molecular Weight: 469.39
  • MDL number: MFCD28502165
  • Update Date: 2026-02-02 18:10:39
VLX1570 Structural

What is VLX1570?

Description

VLX1570 is an inhibitor of 19S proteasomal deubiquitinases with IC50 values of 6.4 and 13 μM for deubiquitinase activity in vitro using Ub-rhodamine and Ub-AMC, respectively, as substrates. It is selective for proteasomal deubiquitinases over a panel of deubiquitinases at 20 μM, but inhibits USP5 by greater than 50%, and over a panel of 211 kinases at 10 μM, but inhibits Cdk4 by 77%. VLX1570 binds to and inhibits recombinant ubiquitin-specific protease 14 (USP14) and ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCHL5) in vitro, and inhibits the USP14 and UCHL5 activity of purified 19S proteasomes when used at a concentration of 50 μM. It inhibits the proliferation of KMS-11, RPMI-8226, OPM-2, and OPM-2-BZR multiple myeloma cells (IC50s = 43, 74, 126, and 191 nM, respectively), as well as induces apoptosis and increases the accumulation of polyubiquitinated proteins. VLX1570 (3 mg/kg per day for 10 days) increases survival and reduces tumor growth in KMS-11-LUC2 and RPMI-8226 mouse xenograft models, respectively.

The Uses of VLX1570

VLX1570 is a proteasome deubiquitinase inhibitor. It also exhibits antineoplastic activities.

Properties of VLX1570

storage temp.  Store at -20°C
solubility  DMF:25.0(Max Conc. mg/mL);53.26(Max Conc. mM)
DMF:PBS (pH 7.2) (1:2):0.3(Max Conc. mg/mL);0.64(Max Conc. mM)
DMSO:47.0(Max Conc. mg/mL);100.13(Max Conc. mM)
form  A crystalline solid
color  Light yellow to yellow

Safety information for VLX1570

Computed Descriptors for VLX1570

Related products of tetrahydrofuran

You may like

  • Bendamustine deschloroethyl acid ethyl ester 2517968-40-8 NLT 95%
    Bendamustine deschloroethyl acid ethyl ester 2517968-40-8 NLT 95%
    2517968-40-8
    View Details
  • Acebutolol EP Impurity K NLT 95%
    Acebutolol EP Impurity K NLT 95%
    74143-33-2
    View Details
  • Clidinium Bromide Impurity NLT 95%
    Clidinium Bromide Impurity NLT 95%
    .6581-06-2
    View Details
  • 192110-67-2 NLT 95%
    192110-67-2 NLT 95%
    192110-67-2
    View Details
  • Cetirizine EP Impurity A/Cetirizine CBHP Impurity NLT 95%
    Cetirizine EP Impurity A/Cetirizine CBHP Impurity NLT 95%
    59872-62-1
    View Details
  • 90717-17-2 Ketamine Impurity-C NLT 95%
    90717-17-2 Ketamine Impurity-C NLT 95%
    90717-17-2
    View Details
  • .2005-04-1 N-Nitroso hydroxy Cetrizine EP Impurity-A NLT 95%
    .2005-04-1 N-Nitroso hydroxy Cetrizine EP Impurity-A NLT 95%
    .2005-04-1
    View Details
  • 145773-22-1 Lantanoprost rc B NLT 95%
    145773-22-1 Lantanoprost rc B NLT 95%
    145773-22-1
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.